Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity - PubMed (original) (raw)
Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity
Brian J Nickoloff et al. Cancer Res. 2004.
Abstract
Cell senescence is a physiological program of terminal growth arrest, which is believed to play an important role in cancer prevention. Senescent cells secrete multiple growth-regulatory proteins, some of which can affect tumor growth, survival, invasion, or angiogenesis. Changes in expression of different senescence-associated genes were analyzed in cultured human skin keratinocytes (KCs) that underwent replicative senescence or confluence-induced accelerated senescence. Senescent KC cultures showed a strong increase in mRNA and protein expression of maspin, a member of serine protease inhibitor family and an epithelial cell tumor suppressor with anti-invasive and antiangiogenic activities. Immunohistochemical analysis of 14 normal human skin samples (age range from 3 months to 84 years) showed that maspin is expressed by KCs in vivo and that the extent and intensity of maspin expression in the skin is significantly (P = 0.01) correlated with chronological age. Antiangiogenic activity of maspin secreted by senescent KCs was investigated in vitro by testing the effect of conditioned media from different KC cultures on endothelial cell migration in the presence or absence of several angiogenic factors. Media conditioned by senescent cultures (undergoing replicative or accelerated senescence), but not by proliferating KCs, strongly inhibited the stimulation of endothelial cell migration by all of the tested angiogenic factors. Neutralizing antibody against maspin abrogated this effect of conditioned media. These findings indicate that senescent KCs exert a paracrine antiangiogenic activity, and maspin is the principal contributor to this potentially tumor-suppressive effect of cellular senescence.
Similar articles
- Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.
Maass N, Hojo T, Zhang M, Sager R, Jonat W, Nagasaki K. Maass N, et al. Acta Oncol. 2000;39(8):931-4. doi: 10.1080/02841860050215909. Acta Oncol. 2000. PMID: 11206999 Review. - Expression and regulation of tumor suppressor gene maspin in breast cancer.
Maass N, Nagasaki K, Ziebart M, Mundhenke C, Jonat W. Maass N, et al. Clin Breast Cancer. 2002 Oct;3(4):281-7. doi: 10.3816/CBC.2002.n.032. Clin Breast Cancer. 2002. PMID: 12425757 - Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS, Torio B, Albergaria A, Schmitt FC. Reis-Filho JS, et al. Virchows Arch. 2002 Dec;441(6):551-8. doi: 10.1007/s00428-002-0710-1. Epub 2002 Sep 25. Virchows Arch. 2002. PMID: 12461611 - Multiple functions of maspin in tumor progression and mouse development.
Zhang M. Zhang M. Front Biosci. 2004 Sep 1;9:2218-26. doi: 10.2741/1392. Front Biosci. 2004. PMID: 15353283 Review.
Cited by
- Inhibitory effect of maspinon neovascularization in diabetic retinopathy.
Qiu F, Tong HJ. Qiu F, et al. World J Diabetes. 2021 Dec 15;12(12):2050-2057. doi: 10.4239/wjd.v12.i12.2050. World J Diabetes. 2021. PMID: 35047119 Free PMC article. - Paracrine proliferative signaling by senescent cells in world health organization group 3 pulmonary hypertension: age corrupting youth?
Ryan JJ, Rehman J, Archer SL. Ryan JJ, et al. Circ Res. 2011 Aug 19;109(5):476-9. doi: 10.1161/CIRCRESAHA.111.251579. Circ Res. 2011. PMID: 21852552 Free PMC article. No abstract available. - Maspin expression in epithelial skin tumours: an immunohistochemical study.
Abdou AG, Maraee AH, El-Monaem Shoeib MA, Abo Saida AM. Abdou AG, et al. J Cutan Aesthet Surg. 2011 May;4(2):111-7. doi: 10.4103/0974-2077.85028. J Cutan Aesthet Surg. 2011. PMID: 21976902 Free PMC article. - Multiple functions of p21 in cancer radiotherapy.
Kuang Y, Kang J, Li H, Liu B, Zhao X, Li L, Jin X, Li Q. Kuang Y, et al. J Cancer Res Clin Oncol. 2021 Apr;147(4):987-1006. doi: 10.1007/s00432-021-03529-2. Epub 2021 Feb 5. J Cancer Res Clin Oncol. 2021. PMID: 33547489 Review. - Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans.
Bascones-Martínez A, López-Durán M, Cano-Sánchez J, Sánchez-Verde L, Díez-Rodríguez A, Aguirre-Echebarría P, Alvarez-Fernández E, González-Moles MA, Bascones-Ilundain J, Muzio LL, Campo-Trapero J. Bascones-Martínez A, et al. Oncol Lett. 2012 Jun;3(6):1319-1325. doi: 10.3892/ol.2012.649. Epub 2012 Mar 19. Oncol Lett. 2012. PMID: 22783442 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- K02 DE00470/DE/NIDCR NIH HHS/United States
- R01 AG17921/AG/NIA NIH HHS/United States
- R01 AR47307/AR/NIAMS NIH HHS/United States
- R01 AR47814/AR/NIAMS NIH HHS/United States
- R01 CA89636/CA/NCI NIH HHS/United States
- R01 DE12322/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources